XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 28, 2024 | (Q4)Dec 28, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.54%3.41B | -3.93%829.4M | -4.83%830.7M | -5.43%885.5M | -3.91%862.6M | 0.45%3.57B | -3.36%863.3M | 1.42%872.9M | 3.25%936.3M | 897.7M |
Operating revenue | -4.54%3.41B | -3.93%829.4M | -4.83%830.7M | -5.43%885.5M | -3.91%862.6M | 0.45%3.57B | -3.36%863.3M | 1.42%872.9M | 3.25%936.3M | --897.7M |
Cost of revenue | -7.31%2.05B | -5.99%494.1M | -6.53%494.9M | -9.51%528.1M | -6.99%532.6M | -4.01%2.21B | -9.89%525.6M | -3.94%529.5M | 0.52%583.6M | 572.6M |
Gross profit | -0.03%1.36B | -0.71%335.3M | -2.21%335.8M | 1.33%357.4M | 1.51%330M | 8.66%1.36B | 8.94%337.7M | 10.95%343.4M | 8.12%352.7M | 325.1M |
Operating expense | -1.41%870M | 1.70%221.9M | 3.05%219.3M | -1.00%217.8M | -8.82%211M | 3.34%882.4M | 1.72%218.2M | 7.37%212.8M | 5.97%220M | 231.4M |
Selling and administrative expenses | -1.38%870M | 1.74%222M | 3.10%219.3M | -1.00%217.7M | -8.82%211M | 3.34%882.2M | 1.72%218.2M | 7.37%212.7M | 5.98%219.9M | --231.4M |
-General and administrative expense | -1.38%870M | 1.74%222M | 3.10%219.3M | -1.00%217.7M | -8.82%211M | 3.34%882.2M | 1.72%218.2M | 7.37%212.7M | 5.98%219.9M | --231.4M |
Other operating expenses | ---- | ---- | ---- | 0.00%100K | ---- | 0.00%200K | --0 | 0.00%100K | 0.00%100K | ---- |
Operating profit | 2.52%488.5M | -5.10%113.4M | -10.80%116.5M | 5.20%139.6M | 27.00%119M | 20.12%476.5M | 25.13%119.5M | 17.34%130.6M | 11.89%132.7M | 93.7M |
Net non-operating interest income expense | 2.47%-142.1M | -4.98%-31.6M | 9.01%-32.3M | -12.35%-46.4M | 18.04%-31.8M | -4.52%-145.7M | 29.34%-30.1M | -8.56%-35.5M | -27.86%-41.3M | -38.8M |
Non-operating interest income | -21.71%13.7M | -69.88%2.5M | -30.00%2.8M | -15.63%2.7M | 185.00%5.7M | --17.5M | --8.3M | 566.67%4M | 357.14%3.2M | --2M |
Non-operating interest expense | -13.89%132.7M | -8.89%32.8M | -10.22%33.4M | -23.88%32.2M | -11.14%34.3M | 10.55%154.1M | -22.08%36M | 18.10%37.2M | 36.45%42.3M | --38.6M |
Total other finance cost | 153.85%23.1M | -45.83%1.3M | -26.09%1.7M | 668.18%16.9M | 45.45%3.2M | --9.1M | --2.4M | 27.78%2.3M | 10.00%2.2M | --2.2M |
Other net income (expense) | 59.56%-18.4M | 134.27%6.1M | -76.47%-15M | 71.43%-3M | 25.29%-6.5M | -9,200.00%-45.5M | -157.98%-17.8M | 24.11%-8.5M | 28.57%-10.5M | -8.7M |
Gain on sale of security | 426.19%13.7M | 348.15%6.7M | 35.71%1.9M | 430.77%4.3M | 150.00%800K | ---4.2M | ---2.7M | 137.84%1.4M | 84.15%-1.3M | ---1.6M |
Special income (charges) | 20.00%-29.2M | 78.71%-3.3M | -119.48%-16.9M | 47.37%-4M | 12.28%-5M | -187.40%-36.5M | -1,191.67%-15.5M | -30.51%-7.7M | -76.74%-7.6M | ---5.7M |
-Less:Restructuring and merger&acquisition | -28.99%9.8M | 92.86%2.7M | -30.77%2.7M | 0.00%2.8M | -71.93%1.6M | 18.97%13.8M | 16.67%1.4M | -27.78%3.9M | -24.32%2.8M | --5.7M |
-Less:Other special charges | -70.35%6.7M | -95.04%700K | -62.16%1.4M | -75.00%1.2M | --3.4M | --22.6M | --14.1M | --3.7M | --4.8M | ---- |
-Write off | --0 | --0 | --0 | ---- | ---- | -90.91%100K | --0 | -80.00%100K | ---- | ---- |
-Gain on sale of business | ---12.7M | --100K | ---12.8M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Other non- operating income (expenses) | 39.58%-2.9M | 575.00%2.7M | ---- | -106.25%-3.3M | -64.29%-2.3M | -136.36%-4.8M | -97.71%400K | -37.50%-2.2M | 27.27%-1.6M | ---1.4M |
Income before tax | 14.97%328M | 22.77%87.9M | -20.09%69.2M | 11.50%90.2M | 74.68%80.7M | 10.67%285.3M | -14.35%71.6M | 28.49%86.6M | 12.99%80.9M | 46.2M |
Income tax | 279.86%107.5M | 1,845.83%46.7M | 1,300.00%14M | 28.13%12.3M | 125.49%34.5M | 89.93%28.3M | 136.36%2.4M | -91.23%1M | -21.95%9.6M | 15.3M |
Net income | -14.24%219.9M | -40.52%41.1M | -35.56%55.1M | 8.99%77.6M | 50.65%46.1M | 5.73%256.4M | -23.31%69.1M | 52.68%85.5M | 20.47%71.2M | 30.6M |
Net income continuous Operations | -14.20%220.5M | -40.46%41.2M | -35.51%55.2M | 9.26%77.9M | 49.51%46.2M | 5.80%257M | -23.28%69.2M | 52.86%85.6M | 20.24%71.3M | --30.9M |
Net income discontinuous operations | 0.00%-600K | 0.00%-100K | 0.00%-100K | -200.00%-300K | 66.67%-100K | -50.00%-600K | 0.00%-100K | ---100K | 50.00%-100K | ---300K |
Minority interest income | 6.38%25M | -27.42%4.5M | 10.29%7.5M | 9.52%6.9M | 45.24%6.1M | 8.29%23.5M | 19.23%6.2M | 65.85%6.8M | 5.00%6.3M | 4.2M |
Net income attributable to the parent company | -16.32%194.9M | -41.81%36.6M | -39.52%47.6M | 8.94%70.7M | 51.52%40M | 5.48%232.9M | -25.91%62.9M | 51.64%78.7M | 22.22%64.9M | 26.4M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -16.32%194.9M | -41.81%36.6M | -39.52%47.6M | 8.94%70.7M | 51.52%40M | 5.48%232.9M | -25.91%62.9M | 51.64%78.7M | 22.22%64.9M | 26.4M |
Basic earnings per share | -11.90%0.74 | -41.67%0.14 | -40.00%0.18 | 12.50%0.27 | 66.67%0.15 | 9.09%0.84 | -20.00%0.24 | 66.67%0.3 | 26.32%0.24 | 0.09 |
Diluted earnings per share | -11.90%0.74 | -41.67%0.14 | -37.93%0.18 | 13.04%0.26 | 66.67%0.15 | 9.09%0.84 | -20.00%0.24 | 61.11%0.29 | 21.05%0.23 | 0.09 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |